已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer

医学 内科学 危险系数 肿瘤科 转移性乳腺癌 癌症 乳腺癌 卡培他滨 置信区间 结直肠癌
作者
Ying‐Yi Lin,Hongfei Gao,Hong Li,Qiong Hu,Bole Du,Sheng Li,Fang‐ping Xu,Minyi Cheng,Jiachen Zou,Xingxing Zheng,Teng Zhu,Kun Wang
出处
期刊:International Journal of Cancer [Wiley]
卷期号:155 (4): 697-709 被引量:13
标识
DOI:10.1002/ijc.34945
摘要

Patient-derived organoids (PDOs) may facilitate treatment selection. This retrospective cohort study evaluated the feasibility and clinical benefit of using PDOs to guide personalized treatment in metastatic breast cancer (MBC). Patients diagnosed with MBC were recruited between January 2019 and August 2022. PDOs were established and the efficacy of customized drug panels was determined by measuring cell mortality after drug exposure. Patients receiving organoid-guided treatment (OGT) were matched 1:2 by nearest neighbor propensity scores with patients receiving treatment of physician's choice (TPC). The primary outcome was progression-free survival. Secondary outcomes included objective response rate and disease control rate. Targeted gene sequencing and pathway enrichment analysis were performed. Forty-six PDOs (46 of 51, 90.2%) were generated from 45 MBC patients. PDO drug screening showed an accuracy of 78.4% (95% CI 64.9%-91.9%) in predicting clinical responses. Thirty-six OGT patients were matched to 69 TPC patients. OGT was associated with prolonged median progression-free survival (11.0 months vs. 5.0 months; hazard ratio 0.53 [95% CI 0.33-0.85]; p = .01) and improved disease control (88.9% vs. 63.8%; odd ratio 4.26 [1.44-18.62]) compared with TPC. The objective response rate of both groups was similar. Pathway enrichment analysis in hormone receptor-positive, human epidermal growth factor receptor 2-negative patients demonstrated differentially modulated pathways implicated in DNA repair and transcriptional regulation in those with reduced response to capecitabine/gemcitabine, and pathways associated with cell cycle regulation in those with reduced response to palbociclib. Our study shows that PDO-based functional precision medicine is a feasible and effective strategy for MBC treatment optimization and customization.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
胡萝卜完成签到 ,获得积分10
1秒前
赵赶超完成签到,获得积分10
1秒前
Shamy完成签到 ,获得积分10
1秒前
肉卷完成签到 ,获得积分10
1秒前
机智若云完成签到,获得积分0
1秒前
庾傀斗发布了新的文献求助10
2秒前
万能的悲剧完成签到 ,获得积分10
2秒前
mlp完成签到 ,获得积分10
2秒前
2秒前
always完成签到 ,获得积分10
2秒前
u826069发布了新的文献求助60
2秒前
清新的安白完成签到,获得积分10
2秒前
研友_851KE8发布了新的文献求助10
2秒前
所所的应助被科研通管家采纳,获得10
3秒前
无花果的应助被科研通管家采纳,获得10
3秒前
浪老师完成签到 ,获得积分10
3秒前
吖咪h完成签到 ,获得积分10
3秒前
Akim的应助被科研通管家采纳,获得10
3秒前
tx的应助被科研通管家采纳,获得10
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
小二郎的应助被科研通管家采纳,获得10
3秒前
Sanction发布了新的文献求助10
3秒前
Owen的应助被科研通管家采纳,获得10
3秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
情怀的应助被科研通管家采纳,获得10
4秒前
庾傀斗发布了新的文献求助10
4秒前
wanci的应助被科研通管家采纳,获得10
4秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
邢绿凝发布了新的文献求助10
4秒前
4秒前
上官若男的应助被科研通管家采纳,获得10
4秒前
xin完成签到,获得积分10
5秒前
庾傀斗发布了新的文献求助10
5秒前
冷静完成签到,获得积分10
5秒前
庚辰梦秋完成签到,获得积分10
5秒前
鲸鱼完成签到 ,获得积分10
5秒前
5秒前
尘南浔完成签到 ,获得积分10
5秒前
wren完成签到,获得积分0
5秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184764
求助须知:如何正确求助?哪些是违规求助? 9573733
关于积分的说明 21832921
捐赠科研通 7782115
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558528
邀请新用户注册赠送积分活动 2481067